Top 50 Genomic Sequencing

Provides an integrated platform for low-pass whole genome sequencing, combining assay development, scalable sequencing, and cloud-based data analytics to deliver cost-effective genomic insights. Enables applications in human, plant, and animal genomics, such as predicting disease risk, identifying genetic traits, and optimizing breeding strategies, while streamlining data processing and management for researchers and industry professionals.

Nebula Genomics offers Whole Genome Sequencing that decodes 100% of an individual's DNA, providing comprehensive insights into health risks, ancestry, and genetic traits. Utilizing blockchain technology, the platform ensures users maintain full ownership and privacy of their genomic data while receiving regular updates based on the latest scientific research.

Ultima Genomics develops a low-cost sequencing platform that utilizes advanced sequencing technologies to provide accurate genomic data. This platform addresses the high costs associated with genomic sequencing, making it more accessible for research and clinical applications.

Loop Genomics provides a platform for long-read DNA sequencing that enhances genomic research by integrating advanced target capture workflows. This technology addresses the need for high-accuracy sequencing at lower costs, enabling researchers to obtain reliable data efficiently.

Nucleus offers whole-genome sequencing that analyzes 100% of an individual's DNA, providing insights into genetic risks for over 800 health conditions, including cancers and heart disease. This technology enables users to understand their unique genetic predispositions and make informed lifestyle choices to enhance their health outcomes.

Confluence Genetics provides high‑coverage whole‑genome and whole‑exome sequencing on Illumina NovaSeq and PacBio HiFi platforms, coupled with an automated cloud‑based pipeline that performs alignment, variant calling and annotation using tools such as BWA‑MEM, GATK and DeepVariant. The service delivers HIPAA‑compliant, encrypted data storage and offers API/FHIR endpoints for integration with EHRs and LIMS, along with customizable reports on pathogenic, pharmacogenomic and novel variants. It serves academic labs, pharmaceutical R&D, clinical genetics and hospital precision‑medicine programs seeking reliable sequencing and interpretive analytics.

This startup offers whole genome sequencing technology that analyzes 100% of an individual's DNA, providing detailed insights into health risks, medication responses, and nutritional needs. By delivering personalized reports based on genetic data, the company empowers users to make informed health decisions and improve their overall well-being.

Sequentify develops the InfiniSeq™ workflow and InfiniSeqKit for genomic sample processing, focusing on efficient library preparation for next-generation sequencing. By reducing the cost and complexity of sample preparation, Sequentify addresses the significant expense and bottleneck in the sequencing process, enabling scalable genomic diagnostics and therapeutics.

Enigma Genomics utilizes next-generation sequencing technologies and artificial intelligence to decode individual genomes, providing personalized genetic insights that inform health decisions. The platform enables users to access and control their genetic data for life, facilitating proactive disease prevention and tailored medical treatments.

Inocras Inc. utilizes whole genome sequencing and a proprietary bioinformatics platform to provide detailed genetic insights for patients with cancer and rare diseases. This technology identifies complex mutations often missed by standard tests, enabling more accurate diagnoses and personalized treatment options.

The startup has developed a genome-analysis platform that facilitates the acquisition, analysis, and storage of genomic data without the need for repeated sequencing of the same genome for different tests. This technology enables healthcare providers to efficiently manage genetic data and deliver precise DNA sequencing services, enhancing the overall effectiveness of genomic research and patient care.

SeqOne provides a clinical decision support platform that utilizes AI-driven bioinformatics to analyze next-generation sequencing (NGS) data for germline and somatic variants. The platform enhances diagnostic accuracy and efficiency by identifying complex genomic events that standard pipelines often overlook, thereby improving patient outcomes in precision medicine.

Watchmaker Genomics develops high-performance enzymes and library preparation kits for next-generation sequencing (NGS) applications, addressing the limitations of current reagents that hinder accurate genomic analysis. Their products enhance throughput and sensitivity for a range of applications, including single-cell sequencing and CRISPR-based editing, enabling researchers to obtain reliable data from diverse sample types.

Intelliseq provides a cloud-based platform for automated analysis and clinical interpretation of Next Generation Sequencing (NGS) genetic data, enabling users to generate actionable insights without requiring bioinformatics expertise. The platform addresses the need for efficient and accurate genomic diagnostics by offering customizable workflows for various medical applications, including diagnostics, therapy, and prevention.

Haystack develops a next-generation genomic testing platform that utilizes next-generation sequencing (NGS) technology to rapidly identify over 1,200 pathogens associated with infectious diseases, including antibiotic resistance profiles. The platform delivers results in under 12 hours, enabling clinicians to make timely and informed treatment decisions for patients at risk of sepsis and other life-threatening infections.

Human Longevity utilizes genomic sequencing and precision diagnostics to create personalized health plans that enhance early detection and treatment of diseases. By analyzing an individual's genetic makeup and health data, the company empowers clients to proactively manage their health and extend their lifespan.

UGenome provides a cloud‑native platform that automates end‑to‑end processing of high‑throughput sequencing data, including alignment, variant calling with tools such as GATK and DeepVariant, and functional annotation via Ensembl VEP and ClinVar. The system runs on containerized Kubernetes clusters, offering scalable compute, real‑time QC dashboards, and secure, searchable storage compliant with GDPR and HIPAA. Users can build custom workflows through a drag‑and‑drop composer or API, enabling reproducible analysis for academic, biotech, and pharmaceutical labs.

Haplotype develops software that reduces genomic sequencing costs by 50% to 90% while utilizing polygenic risk models to predict, detect, and prevent diseases. The platform accelerates genetic analysis by streamlining workflows and eliminating the need for custom software pipelines.

The startup develops a single-cell sequencing technology that utilizes patented split-pool barcoding and combinatorial indexing methods to enhance sample indexing and cell throughput. This technology enables researchers to conduct a wide range of genomic, epigenomic, transcriptomic, and proteogenomic analyses efficiently.

Plasmidsaurus provides overnight sequencing of whole plasmids, amplicons, and bacterial genomes without the need for primers or minipreps, enabling rapid and cost-effective analysis. This service addresses the challenges of traditional sequencing methods by eliminating delays and reducing costs associated with oligo synthesis, allowing researchers to verify sample identity and purity efficiently.

The startup provides genomic profiling services that enable individuals to assess their genetic predisposition to diseases, particularly cancer, through advanced DNA sequencing and analysis. By identifying genetic risks early, the company facilitates timely interventions and personalized treatment strategies based on individual genetic profiles.

Arima Genomics utilizes 3D genomics and Hi-C technology to provide detailed insights into the sequence, structure, and regulatory landscape of genomes, enabling the identification of novel biomarkers and therapeutic targets. Their solutions facilitate rapid genome assembly and analysis, addressing the need for comprehensive genomic characterization in cancer research and human health.

Vitract utilizes genomic sequencing to analyze gut microbiome composition and identify biomarkers that impact digestive, metabolic, and mental health. By combining gut testing with personalized nutrition coaching, Vitract addresses the root causes of mental illness and promotes overall wellness through tailored dietary recommendations.

Anthology Diagnostics offers advanced cancer genomic testing using next-generation sequencing (NGS) and biomarker analysis. We provide oncologists with clinically actionable molecular data for personalized treatment decisions in solid tumors and hematologic malignancies.

OneCell Diagnostics specializes in precision oncology through liquid biopsy diagnostics, utilizing advanced genomic sequencing techniques to detect cancer-related mutations in circulating tumor DNA. This technology enables early cancer detection and personalized treatment plans, improving patient outcomes and reducing the need for invasive procedures.

OmniSeq provides tissue-based sequencing tests for late-stage solid tumors, delivering actionable tumor-profiling information to physicians and their patients. This technology enables personalized treatment decisions by identifying specific genetic alterations that can inform targeted therapies.

Variantyx offers a cloud‑based whole‑genome sequencing platform, Genomic Unity® 2.0, that starts with an indication‑specific panel and automatically reflexes to exome‑plus or full‑genome analysis from a single specimen. Its AI‑driven bioinformatics pipeline delivers comprehensive variant calls—including SNVs, CNVs, repeat expansions, and mitochondrial variants—and generates HIPAA‑compliant, FHIR‑compatible reports that integrate directly into EHRs. The service includes a same‑day “Lightning Genome” option for critical neonatal cases and a customizable test catalog for rare disease, prenatal, cancer, and wellness screening.

Saphetor provides the VarSome Suite, a set of bioinformatics solutions that processes Next Generation Sequencing (NGS) data to generate clinically relevant genetic variation information. This technology enables healthcare professionals and researchers to access a comprehensive knowledge base and automated classification tools, enhancing the accuracy and efficiency of genomic analysis.

Cradle Genomics has developed a novel prenatal testing methodology that utilizes advanced genomic sequencing techniques to detect genetic abnormalities in fetuses. This technology provides expectant parents with early and accurate information about potential health issues, enabling informed decision-making during pregnancy.

This startup offers whole genome sequencing and genetic testing services to identify health risks and inform personalized medicine. They provide genetic counseling and bioinformatics tools to patients and healthcare providers for accurate genetic analysis.

GenomeKey utilizes advanced genomic sequencing technology to analyze genetic data for personalized medicine applications. The company provides insights that enhance treatment efficacy and reduce adverse drug reactions, improving patient outcomes in healthcare.

TwinStrand Biosciences utilizes Duplex Sequencing technology to accurately identify ultra-low frequency genomic variants that conventional next-generation sequencing methods cannot detect. This high-resolution approach significantly reduces sequencing error rates, enabling precise insights for applications such as residual cancer detection and genetic toxicology.

Geneyx provides DNA and RNA data analysis and interpretation for whole genome sequencing (WGS), whole exome sequencing (WES), gene panels, and microarrays, enabling rapid transformation of raw genetic data into clinical reports. The platform enhances diagnostic accuracy and efficiency, aiming to eliminate undiagnosed diseases by increasing the diagnostic yield and reducing turnaround times for genetic testing.

MGI Tech develops genetic sequencers and lab automation tools that enhance genomic analysis and streamline sample preparation processes in life sciences. Their technology addresses the need for efficient, high-throughput sequencing and data management, enabling precise diagnostics and research in healthcare and agriculture.

GenomeKey employs genomic sequencing technology to analyze genetic data for early disease detection and the formulation of personalized treatment plans. By providing precise genomic insights, the company enhances patient outcomes through targeted healthcare interventions.

Paragon Genomics provides CleanPlex® amplicon-based next-generation sequencing (NGS) panels that enable precise target enrichment for genomic testing in areas such as infectious disease and precision oncology. Their technology addresses the need for high sensitivity and specificity in detecting low-frequency variants, facilitating rapid and accurate genomic analysis.

This startup offers a genomic diagnostics platform that utilizes DNA sequencing technology to detect genetic disorders and predispositions. By providing accurate genetic data, it enables healthcare providers to tailor patient care based on individual genetic profiles.

The startup specializes in genomics sequencing focused on non-European genomes, utilizing modern and ancient DNA analysis across various sequencing platforms. By providing a diverse genomic database and biobank, the company enables pharmaceutical firms to enhance drug development through insights into disease predisposition and pharmacogenomics.

Foresee Genomics offers an integrated next-generation sequencing (NGS) platform that makes advanced genomic analysis accessible to smaller laboratories. Their solution combines optimized protocols, specialized reagents, and user-friendly bioinformatics tools to reduce costs and lab space requirements. This empowers labs to perform high-accuracy genomic analysis for improved diagnostics and precision medicine.

biomodal develops the duet multiomics solution evoC, which captures both genetic and epigenetic data from a single 5ng DNA sample in one sequencing run, enabling the analysis of 5-methylcytosine and 5-hydroxymethylcytosine alongside the four canonical bases. This technology addresses the limitations of current sequencing methods that fail to provide comprehensive insights from low-input samples, enhancing applications in cancer research, neurodegenerative disease, and precision medicine.

Accuragen provides an end‑to‑end genomic sequencing service that automates library preparation, runs high‑throughput Illumina and long‑read NGS, and delivers cloud‑based bioinformatics results in FASTQ, BAM/CRAM, and VCF formats with standardized variant annotation. Its proprietary error‑correction pipelines achieve >99.9% Q30 base quality and the platform integrates via RESTful API into laboratory information systems, offering a pay‑per‑sample model for academic, pharmaceutical, and clinical genetics users.

Veil Genomics develops advanced genomic sequencing technologies to accelerate disease research and drug discovery. Their platform provides high-throughput, accurate genetic data analysis, enabling scientists to identify biomarkers and therapeutic targets more efficiently.

The startup specializes in DNA sequencing technologies, offering short-read sequencers that deliver ultra-long-range results for diploid genomes of various sizes. This capability enables precise applications such as de novo sequencing and structural variation detection, allowing businesses to efficiently generate customizable sequencing libraries tailored to their specific genomic needs.

The startup operates a cancer diagnostic laboratory that provides genomic profiling for solid and hematologic cancers, utilizing next-generation sequencing technologies to deliver precise genetic insights. By partnering with laboratories, hospitals, and oncology practices, the company enhances diagnostic accuracy and treatment personalization for cancer patients.

Armonica develops proprietary long-read DNA sequencing technology that enables real-time sequencing of ultra-long, native nucleic acid molecules without the need for amplification or labeling. This technology addresses critical gaps in genomic analysis by accurately detecting large structural variants and epigenetic modifications that traditional methods often miss.

XGenomes develops DNA sequencing technologies that utilize optical super-resolution imaging and machine learning to monitor health, detect early disease signals, and track interventions throughout an individual's life. Their platform addresses high error rates and complex workflows in existing sequencing methods, providing a streamlined and cost-effective solution for continuous health monitoring.

Grandomics specializes in third-generation sequencing technology to provide molecular diagnostics and carrier screening for single-gene diseases. Their platform enables accurate detection of genetic variations and complex genomic regions, facilitating precise diagnosis and research in genetic disorders.

Molecular Loop utilizes LoopCap™ technology to integrate target capture and library preparation into a single, scalable workflow for production-scale targeted sequencing applications. This approach addresses the challenges of high-throughput genomic analysis by providing high yield, uniform libraries, and customizable assay design for various research needs.

Shirebio develops custom software pipelines for sequencing data analysis, utilizing a natural language interface tailored for genomics applications. This technology simplifies complex data interpretation, enabling researchers to efficiently analyze genomic sequences without extensive programming knowledge.

Aegicare is an AI-driven platform that provides clinical whole-genome sequencing solutions, utilizing proprietary bioinformatics tools to deliver precise genetic analysis and rare disease interpretation. The platform addresses the challenge of accurate diagnosis in complex genetic conditions, enhancing patient care through tailored genomic insights.